Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07778784) titled 'Evaluation of Cardiovascular Risk Among the Participants of the ESC Congress 2026' on Aug. 18.
Study Type: Observational
Primary Sponsor: European Society of Cardiology
Condition:
Cardiovascular Risks
Intervention:
Biological: Capillary blood draw
Behavioral: Questionnaire and Physical Exam
Biological: Urine sample
Recruitment Status: Not recruiting
Date of First Enrollment: August 28, 2026
Target Sample Size: 1300
To know more, visit https://clinicaltrials.gov/study/NCT07778784
Disclaimer: Curated by HT Syndication....